Search
Filter Results
- Resource Type
- Journal2
- Journal Digital2
- Article1
- Book1
- Article Type
- Clinical Trial1
- Clinical Study1
- Comparative Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog2
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Ann Rheum Dis1
Search Results
Sort by
- JournalSummary: Written in concise and easy-to-understand language, the articles help patients make informed decisions about treatment options and living with a wide-range of neurologic disorders, including multiple sclerosis, Alzheimer's disease, Parkinson's disease, epilepsy, migraine, neuropathy, stroke, amyotrophic lateral sclerosis, sleep disorders, Huntington's disease.Digital Access Ovid v. 14-, 2018-
- JournalSummary: Written in concise and easy-to-understand language, the articles help patients make informed decisions about treatment options and living with a wide-range of neurologic disorders, including multiple sclerosis, Alzheimer's disease, Parkinson's disease, epilepsy, migraine, neuropathy, stroke, amyotrophic lateral sclerosis, sleep disorders, Huntington's disease.Digital Access Ovid v. 14-, 2018-
- ArticleHuskisson EC, Scott J.Ann Rheum Dis. 1978 Feb;37(1):89-92.Trials in patients with rheumatoid arthritis and osteoarthritis showed sulindac to be an analgesic with anti-inflammatory properties and at least as effective as aspirin. It was effective within 24 hours in doses of 300-400 mg daily. It had the advantages of twice daily administration and a lower incidence of gastric side effects than aspirin. Constipation, usually mild, occurred in 20-30% of cases. Like other anti-inflammatory drugs, it was effective in only a proportion of the patients.